VAERS reports by lot

Pfizer COVID-19 lot GK0876: VAERS reports

72 VAERS reports list lot GK0876 as a Pfizer COVID-19 vaccine, received between 2023-02-14 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
72
Reports
4%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular1720%
Respiratory1518%
General / Systemic (non-local)1417%
Thrombotic / Hematological810%
Gastrointestinal67%
Dermatological (non-injection-site)56%
Injection-site / Local reaction56%
Allergic / Anaphylactic45%
Neurological34%
Musculoskeletal34%
Autoimmune / Immune-mediated22%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

California11
Michigan6
New Hampshire6
Illinois5
North Carolina5
Missouri4
Texas4
Indiana3
Colorado3
Ohio3
Tennessee3
New Jersey2

Reports by month received

2023-027
2023-0312
2023-042
2023-0517
2023-0610
2023-078
2023-084
2023-093
2023-104
2024-011
2024-031
2024-063

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.